- Report
- September 2024
- 109 Pages
Philippines
From €2675EUR$3,190USD£2,435GBP
- Report
- September 2024
- 24 Pages
Philippines
From €995EUR$1,186USD£906GBP
- Report
- September 2024
- 218 Pages
China
From €3593EUR$4,000USD£3,160GBP
- Report
- August 2024
- 50 Pages
China
From €1617EUR$1,800USD£1,422GBP
- Report
- August 2024
- 104 Pages
China
From €1617EUR$1,800USD£1,422GBP
- Company Profile
- June 2024
- 53 Pages
From €1100EUR$1,312USD£1,001GBP
- Report
- April 2024
- 73 Pages
China
From €1617EUR$1,800USD£1,422GBP
- Report
- November 2023
- 150 Pages
Global
From €3459EUR$3,850USD£3,041GBP
€4357EUR$4,850USD£3,831GBP
- Report
- September 2023
United States
€13476EUR$15,000USD£11,849GBP
- Database
- July 2023
Global
From €323EUR$360USD£284GBP
- Database
- July 2023
Global
From €323EUR$360USD£284GBP
- Report
- April 2023
- 65 Pages
India
- Database
- April 2023
China
- Database
- April 2023
China
€1797EUR$2,000USD£1,580GBP
- Report
- January 2023
- 271 Pages
Europe
From €4986EUR$5,550USD£4,384GBP
- Database
- January 2023
China
- Report
- May 2022
- 109 Pages
South Africa
From €2560EUR$2,850USD£2,251GBP
- Report
- September 2021
- 19 Pages
Thailand
From €825EUR$984USD£751GBP
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global

The Over the Counter (OTC) Drugs market is a segment of the pharmaceutical industry that includes drugs that can be purchased without a prescription. These drugs are typically used to treat minor ailments such as headaches, colds, and allergies. OTC drugs are generally considered safe and effective when used as directed.
OTC drugs are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. The FDA also requires that OTC drugs be labeled with clear instructions for use.
Some of the major players in the OTC Drugs market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Bayer, and Novartis. These companies produce a wide range of OTC drugs, including pain relievers, cold and flu remedies, antacids, and allergy medications. Show Less Read more